Following the success of the HealthTech Innovation Days‘ first edition in 2019, the purpose of this second event on October 5th & 6th 2020 is to drive and foster collaborations within the European healthcare and life sciences ecosystems.
HTID® brings the European healthcare community together to discuss new trends in research & development.
This symposium also features conferences and panel discussions, networking and private meetings between innovative European HealthTech companies, pharmaceutical companies, life sciences-specialized investors, healthcare experts, KOLs and institutional representatives. In addition to the ongoing private networking, attendees can expect roundtables focused on critical economic and political issues that impact health technology developments.
The HealthTech Innovation Days are intended for publicly listed companies whose market capitalization is at least €20 million, or for privately held biotech firms whose drug candidates are currently undergoing late Phase I studies. For MedTech companies, medical devices must have already obtained the CE mark in Europe or FDA approval in the United States.
What’s new for HTID®?
A mix of physical and virtual event to maximize meeting opportunities that features:
- Private meetings with European innovative companies, pharmaceutical companies and life sciences specialized investors (physical & virtual) through a flexible self-scheduling system,
- Conferences and thematic panel discussions on new trends (on site and online),
- Networking opportunities taking place throughout the event.